Projected Earnings Date: 2025-05-22    (Delayed quote data   2025-05-09)
Last
 46.26
Change
 ⇑ +0.06   (+0.13%)
Volume
  3,763,830
Open
 46.19
High
 46.26
Low
 46.16
8EMA (Daily)
 45.82
40EMA (Daily)
 44.34
50EMA (Daily)
 44.35
STO (Daily)
 98.982
MACD Hist (Daily)
 0.868
8EMA (Weekly)
 44.525
40EMA (Weekly)
 41.92
50EMA (Weekly)
 41.21
STO (Weekly)
 33.519
MACD Hist (Weekly)
 -0.836
SpringWorks Therapeutics Inc is a United States-based biopharmaceutical company. It is focused on identifying, developing, and commercializing therapies for underserved patient populations suffering from severe rare diseases and cancer. The firm's pipeline product includes Mirdametinib, Nirogacestat, and others.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com